Key result
Hemodialysis linked to worse clinical outcomes and higher hematoma enlargement in intracerebral hemorrhage.
Why the study?
Does hemodialysis increase the risk of adverse outcomes and hematoma enlargement in patients with intracerebral hemorrhage?
Cohort (n=445)
Does hemodialysis increase the risk of adverse outcomes and hematoma enlargement in patients with intracerebral hemorrhage?
Answers are grounded in this paper and cite their sources.
Hemodialysis patients with intracerebral hemorrhage have a higher risk of hematoma enlargement and poorer clinical outcomes compared to non-hemodialysis patients.
BACKGROUND: Chronic kidney failure is a global public health challenge and is associated with a higher risk of intracerebral hemorrhage (ICH). ICH is known to result in a poorer prognosis in hemodialysis (HD) patients than in non-HD patients. METHODS: This retrospective study examined 445 consecutive cases of ICH to investigate the disparities in outcomes between HD (44 cases) and non-HD (401 cases) patients. The 2 groups were compared based on demographic and clinical factors, and multivariate analyses were performed to identify risk factors for adverse outcomes. RESULTS: The HD group showed a significantly younger age (68.1 vs. 72.9, P = 0.01) and higher frequencies of hypertension, diabetes, anticoagulant use, a history of smoking, and a history of stroke. Clinical outcomes were worse in the HD group (P < 0.01). Detailed analysis of ICH characteristics revealed a higher rate of hematoma enlargement in the HD group (P < 0.01). Multivariate analysis confirmed dialysis and anticoagulant use as significant risk factors for hematoma enlargement. CONCLUSIONS: The study concludes that HD patients with ICH exhibit a higher risk of hematoma enlargement and poorer clinical outcomes. Dialysis and anticoagulant use emerged as significant risk factors for hematoma enlargement. Larger prospective studies are essential for validating these findings.
No takes yet. Share an insight, caveat, or question.
Karita et al. (2025) conducted a cohort in Intracerebral hemorrhage (n=445). Hemodialysis vs. Non-hemodialysis was evaluated on Clinical outcomes and hematoma enlargement (p=<0.01). Hemodialysis in patients with intracerebral hemorrhage was associated with worse clinical outcomes and a higher rate of hematoma enlargement compared to non-hemodialysis patients.
Synapse has enriched 10 related papers. Consider them for comparative context: